Molecular pathophysiology of Philadelphia-negative myeloproliferative disorders: beyond JAK2 and MPL mutations
Haematologica (2008) 93: 972-976.
Authors: Alessandro M. Vannucchi and Paola Guglielmelli
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
PLoS Medicine (2006) 3: 1140-1151
Authors: Yana Pikman1, Benjamin H. Lee1, Thomas Mercher1, Elizabeth McDowell1, Benjamin L. Ebert2,3, Maricel Gozo1, Adam Cuker1, Gerlinde Wernig1, Sandra Moore1, Ilene Galinsky2, Daniel J. DeAngelo2, Jennifer J. Clark2, Stephanie J. Lee2, Todd R. Golub2,3,4, Martha Wadleigh2, D. Gary Gilliland1,2,4, Ross L. Levine1,2*
Evidence for MPL W515L/K mutations in hematopoietic stem cells in primitive Myelofibrosis
Blood (2007) 110: 3735-3743.
Authors: Ronan Chaligne,Chloe James, Carole Tonetti, Rodolphe Besancenot, Jean Pierre Le Couedic, Fanny Fava, Frederic Mazurier, Isabelle Godin, Karim Maloum, Frederic Larbret, Yann Lecluse, William Vainchenker, and
Stephane Giraudier
MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients
Blood (2006) 108: 3472-3476.
Authors: Animesh D. Pardanani, Ross L. Levine, Terra Lasho, Yana Pikman, Ruben A. Mesa, Martha Wadleigh, David P. Steensma, Michelle A. Elliott, Alexandra P. Wolanskyj, William J. Hogan, Rebecca F. McClure, Mark R. Litzow, D. Gary Gilliland, and Ayalew Tefferi
Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations
Haematologica (2007) 92: 1186-1193.
Authors: Anna Savoia, Carlo Dufour, Franco Locatelli, Patrizia Noris, Chiara Ambaglio, Vittorio Rosti,Marco Zecca, Simona Ferrari, Filomena di Bari, Anna Corcione, Mariateresa Di Stazio, Marco Seri, Carlo L. Balduini
